Swiss National Bank

Holdings History for Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)

Symbol: AKBA on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$799,687	496,700	-12,600	-2.5%	$1.61	Q4 2025
30 Sep 2025	0%	+0%	$1,390,389	509,300	+509,300	NEW	$2.73	Q3 2025
30 Jun 2022		-0%	$0	0	-393,085	-100%	$1.41	Q2 2022
31 Mar 2022	0%	+0%	$282,000	393,085	+28,300	+7.8%	$0.72	Q1 2022
31 Dec 2021	0%	+0%	$824,000	364,785	+28,700	+8.5%	$2.26	Q4 2021
30 Sep 2021	0%	+0%	$968,000	336,085	+14,600	+4.5%	$2.88	Q3 2021
30 Jun 2021	0%	+0%	$1,218,000	321,485	+7,700	+2.5%	$3.79	Q2 2021
31 Mar 2021	0%	+0%	$1,062,000	313,785	+9,700	+3.2%	$3.38	Q1 2021
31 Dec 2020	0%	0%	$851,000	304,085	0		$2.80	Q4 2020
30 Sep 2020	0%	+0%	$763,000	304,085	+51,800	+21%	$2.51	Q3 2020
30 Jun 2020	0%	+0%	$3,426,000	252,285	+102,300	+68%	$13.58	Q2 2020
31 Mar 2020	0%	+0%	$1,137,000	149,985	+2,100	+1.4%	$7.58	Q1 2020
31 Dec 2019	0%	+0%	$935,000	147,885	+4,100	+2.9%	$6.32	Q4 2019
30 Sep 2019	0%	+0%	$564,000	143,785	+5,200	+3.8%	$3.92	Q3 2019
30 Jun 2019	0%	0%	$671,000	138,585	0		$4.84	Q2 2019
31 Mar 2019	0%	-0%	$1,135,000	138,585	-5,900	-4.1%	$8.19	Q1 2019
31 Dec 2018	0%	+0%	$799,000	144,485	+66,385	+85%	$5.53	Q4 2018
30 Sep 2018	0%	0%	$690,000	78,100	0		$8.83	Q3 2018
30 Jun 2018	0%	0%	$779,000	78,100	0		$9.97	Q2 2018
31 Mar 2018	0%	+0%	$744,000	78,100	+13,800	+21%	$9.53	Q1 2018
31 Dec 2017	0%	+0%	$956,000	64,300	+64,300	NEW	$14.87	Q4 2017
30 Jun 2015		-0%	$0	0	-17,200	-100%	$1.41	Q2 2015
31 Mar 2015	0%	0%	$191,000	17,200	0		$11.10	Q1 2015
31 Dec 2014	0%	+0%	$200,000	17,200	+17,200	NEW	$11.63	Q4 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.